Neurological Outcome and Quality of Life Three Months after COVID-19: A Prospective Observational Cohort Study

2020 ◽  
Author(s):  
Verena Rass ◽  
Ronny Beer ◽  
Alois Josef Schiefecker ◽  
Mario Kofler ◽  
Anna Lindner ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Cohort Study ◽  
Neurological Outcome ◽  
Observational Cohort Study ◽  
Prospective Observational Cohort Study ◽  
Observational Cohort

Prospective Observational Cohort Study of Health-related Quality of Life

Spine ◽  
2019 ◽  
Vol 44 (24) ◽  
pp. 1723-1730
Author(s):  
Dal-Sung Ryu ◽  
James Ki Shinn ◽  
Byeong-Woo Kim ◽  
Bong-Ju Moon ◽  
Yoon Ha ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Cohort Study ◽  
Observational Cohort Study ◽  
Prospective Observational Cohort Study ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related ◽  
Observational Cohort

scholarly journals The Impact of Childhood Acute Otitis Media on Parental Quality of Life in a Prospective Observational Cohort Study

2015 ◽  
Vol 35 (10) ◽  
pp. 613-624 ◽  
Author(s):  
Katsiaryna Holl ◽  
Mats Rosenlund ◽  
Carlo Giaquinto ◽  
Sven-Arne Silfverdal ◽  
Alfonso Carmona ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Cohort Study ◽  
Otitis Media ◽  
Acute Otitis Media ◽  
Observational Cohort Study ◽  
Prospective Observational Cohort Study ◽  
Parental Quality ◽  
Observational Cohort ◽  
The Impact

scholarly journals Benefits of pulmonary rehabilitation in COVID-19 – a prospective observational cohort study

2021 ◽  
pp. 00108-2021
Author(s):  
Rainer Gloeckl ◽  
Daniela Leitl ◽  
Inga Jarosch ◽  
Tessa Schneeberger ◽  
Christoph Nell ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Cohort Study ◽  
Lung Function ◽  
Exercise Performance ◽  
Pulmonary Rehabilitation ◽  
Observational Cohort Study ◽  
Prospective Observational Cohort Study ◽  
Sf 36 ◽  
Observational Cohort

BackgroundThe new Corona-Virus disease (COVID-19) can result in a large variety of chronic health issues like impaired lung function, reduced exercise performance, and diminished quality of life. Our study aimed to investigate the efficacy, feasibility, and safety of pulmonary rehabilitation (PR) in COVID-19 patients and to compare outcomes between patients with a mild/moderate and a severe/critical course of the disease.MethodsPatients in the post-acute phase of a mild to critical course of COVID-19 admitted to a comprehensive three-week inpatient PR were included in this prospective, observational cohort study. Several measures of exercise performance (6-minute walk distance, 6MWD), lung function (forced vital capacity, FVC), and quality of life (36 question short-form health survey, SF-36) were assessed before and after PR.ResultsFifty patients were included in the study (24 with mild/moderate and 26 with severe/critical COVID-19). On admission, patients had a reduced 6MWD (mild: 509 m [426–539]; severe: 344 m [244–392]), an impaired FVC (mild: 80% [59–91]; severe: 75% [60–91]) and a low SF-36 mental health score (mild: 49 pts [37–54]; severe: 39 pts [30–53]). Patients attended a median of 100% [94–100] of all provided PR sessions. At discharge, patients in both subgroups improved in 6MWD (mild/moderate: +48 m [35–113 m]; severe/critical: +124 m [75–145 m], both p<0.001), FVC (mild/moderate: +7.7% [1.0–17.8], p=0.002; severe/critical: +11.3% [1.0–16.9], p<0.001) and SF-36 mental component (mild/moderate +5.6 pts [1.4–9.2], p=0.071; severe/critical: +14.4 pts [−0.6–24.5], p<0.001). No adverse event was observed.ConclusionOur study shows that PR is a feasible, safe, and effective therapeutic option in COVID-19 patients independent of disease severity.

Sign in / Sign up

Export Citation Format

Share Document